Skip to main content
Journal of Cell Communication and Signaling logoLink to Journal of Cell Communication and Signaling
. 2015 Sep 10;9(3):299. doi: 10.1007/s12079-015-0304-8

Erratum to: Pick of the Year 2014

Bernard Perbal 1,
PMCID: PMC4580682  PMID: 26358046

Erratum to: J. Cell Commun. Signal.

DOI 10.1007/s12079-015-0274-x

This manuscript was erroneously omitted from issue 1 of 2015. The publisher apologizes for this oversight and for any inconvenience that was caused. The introduction refers to the instructions that the invited authors received in the preparation of their contributions to the following Bits & Bytes manuscripts published in issue 1 of the Journal of Cell Communication and Signaling:

Dopamine: an old target in a new therapy by Sushanta K. Banerjee (2015)

How IGF-1 activates its receptor by Robert Baxter (2015)

Heparan sulfate provides a mechanism to respond to FGFR2b and control regenerative expansion by Enrique Brandan (2015)

Cancer resistance, high molecular weight hyaluronic acid, and longevity by Gary J. Fisher (2015)

Stem cell quest by Alexandra Irvine (2015)

Lovastatin rescues human and mice cartilage disorders by Satoshi Kubota (2015)

Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic? By Andrew Leask (2015)

Another dimension to the importance of the extracellular matrix in fibrosis by Laure Rittié (2015)

Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer by David D. Roberts, Sukhbir Kaur and David R. Soto-Pantoja (2015)

Footnotes

The online version of the original article can be found at http://dx.doi.org/10.1007/s12079-015-0274-x.

References

  1. Banerjee SK (2015) Dopamine: an old target in a new therapy. J Cell Commun Signal 9:85–86. doi:10.1007/s12079-015-0275-9 [DOI] [PMC free article] [PubMed]
  2. Baxter R (2015) How IGF-1 activates its receptor. J Cell Commun Signal 9:87. doi:10.1007/s12079-015-0276-8 [DOI] [PMC free article] [PubMed]
  3. Brandan E (2015) Heparan sulfate provides a mechanism to respond to FGFR2b and control regenerative expansion. J Cell Commun Signal 9:89. doi:10.1007/s12079-015-0277-7 [DOI] [PMC free article] [PubMed]
  4. Fisher GJ (2015) Cancer resistance, high molecular weight hyaluronic acid, and longevity. J Cell Commun Signal 9:91–92. doi:10.1007/s12079-015-0278-6 [DOI] [PMC free article] [PubMed]
  5. Irvine A (2015) Stem cell quest. J Cell Commun Signal 9:93. doi:10.1007/s12079-015-0279-5 [DOI] [PMC free article] [PubMed]
  6. Kubota S (2015) Lovastatin rescues human and mice cartilage disorders. J Cell Commun Signal 9:95. doi:10.1007/s12079-015-0280-z [DOI] [PMC free article] [PubMed]
  7. Leask A (2015) Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic? J Cell Commun Signal 9:97–98. doi:10.1007/s12079-015-0281-y [DOI] [PMC free article] [PubMed]
  8. Rittié L (2015) Another dimension to the importance of the extracellular matrix in fibrosis. J Cell Commun Signal 9:99–100. doi:10.1007/s12079-015-0282-x [DOI] [PMC free article] [PubMed]
  9. Roberts DD, Kaur S, Soto-Pantoja DR (2015) Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer. J Cell Commun Signal 9:101–102. doi:10.1007/s12079-015-0283-9 [DOI] [PMC free article] [PubMed]

Articles from Journal of Cell Communication and Signaling are provided here courtesy of The International CCN Society

RESOURCES